Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma

Lauer, U. M.; Awada, A.; Postel-Vinay, S.; Shapiro, G. I.; Thieblemont, C.; Piha-Paul, S. A.; Paik, P. K.; Shepard, D. R.; Docampo, L. I.; Galot, R.; Rottey, S.; Sadrolhefazi, B.; Marzin, K.; Musa, H.; Schoffski, P.

dc.contributor.author	Lauer, Ulrich Manfred
dc.date.accessioned	2025-10-02T12:55:35Z
dc.date.available	2025-10-02T12:55:35Z
dc.date.issued	2025
dc.identifier.issn	2059-7029
dc.identifier.uri	http://hdl.handle.net/10900/170702
dc.language.iso	en	de_DE
dc.publisher	Amsterdam : Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.esmoop.2025.104499	de_DE
dc.subject.ddc	610	de_DE
dc.title	Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_00654
utue.personen.roh	Lauer, U. M.
utue.personen.roh	Awada, A.
utue.personen.roh	Postel-Vinay, S.
utue.personen.roh	Shapiro, G. I.
utue.personen.roh	Thieblemont, C.
utue.personen.roh	Piha-Paul, S. A.
utue.personen.roh	Paik, P. K.
utue.personen.roh	Shepard, D. R.
utue.personen.roh	Docampo, L. I.
utue.personen.roh	Galot, R.
utue.personen.roh	Rottey, S.
utue.personen.roh	Sadrolhefazi, B.
utue.personen.roh	Marzin, K.
utue.personen.roh	Musa, H.
utue.personen.roh	Schoffski, P.
dcterms.isPartOf.ZSTitelID	Esmo Open	de_DE
dcterms.isPartOf.ZS-Issue	5	de_DE
dcterms.isPartOf.ZS-Volume	10	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE